Amarin Corp Plc (AMRN)

[KCSVEN]

If they deny expanded indication best case is a 5-6 BO, the only way they stay a GIA company is if partner comes in and covers expenses until REDUCE IT since successful REDUCE IT equals large BB.

If they somehow screw up BO and partner they will likely go BK and never finish REDUCE IT. They could dilute, cut back, etc... but they have interest payment, promised inventory buys based on Anchor approval etc...I don't see how they finance REDUCE IT, so if FDA wants REDUCE IT results they need to approve Anchor, otherwise they are 6+ years away from a definitive answer as they need someone else to start a similar trial.

If Anchor denied AMRN should just take offers to sell and take the best one. Nothing else would make sense